ERD

Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

A Blueprint for High Affinity SARS-CoV-2 Mpro Inhibitors from Activity-Based Compound Library Screening Guided by Analys...

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

Computational Studies of SARS-CoV-2 3CLpro: Insights from MD Simulations

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

Comparison of Allplex™ SARS-CoV-2 Assay, Easy SARS-CoV-2 WE and Lumipulse quantitative SARS-CoV-2 antigen test perform...

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

SARS-CoV-2 Phylogenetic Analysis, Lazio Region, Italy, February–March 2020

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

A Comprehensive Mapping of the Druggable Cavities within the SARS-CoV-2 Therapeutically Relevant Proteins by Combining P...

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

Combining Different Docking Engines and Consensus Strategies to Design and Validate Optimized Virtual Screening Protocol...

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

Compartmentalized Replication of SARS-Cov-2 in Upper vs. Lower Respiratory Tract Assessed by Whole Genome Quasispecies A...

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

Frequency and Duration of SARS-CoV-2 Shedding in Oral Fluid Samples Assessed by a Modified Commercial Rapid Molecular As...

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

Unraveling the molecular basis of host cell receptor usage in SARS-CoV-2 and other human pathogenic β-CoVs

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

Structural and Biochemical Analysis of the Dual Inhibition of MG-132 against SARS-CoV-2 Main Protease (Mpro/3CLpro) and ...

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

In Vitro Models for Studying Entry, Tissue Tropism, and Therapeutic Approaches of Highly Pathogenic Coronaviruses

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host Cells

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

Investigation of Nasal/Oropharyngeal Microbial Community of COVID-19 Patients by 16S rDNA Sequencing

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

16S rRNA gene sequencing of rectal swab in patients affected by COVID-19

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

Repurposing the estrogen receptor modulator raloxifene to treat SARS-CoV-2 infection

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

Medical treatment options for COVID-19

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

Altered Local Interactions and Long-Range Communications in UK Variant (B.1.1.7) Spike Glycoprotein

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

A method for the rational selection of drug repurposing candidates from multimodal knowledge harmonization

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

Setup and Maintenance of Website & Social Media

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

Performance of a novel diagnostic assay for rapid SARS-CoV-2 antigen detection in nasopharynx samples

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

Virological Characterization of the First 2 COVID-19 Patients Diagnosed in Italy: Phylogenetic Analysis, Virus Shedding ...

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

Natural and Nature-Derived Products Targeting Human Coronaviruses

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

Saliva Is a Valid Alternative to Nasopharyngeal Swab in Chemiluminescence-Based Assay for Detection of SARS-CoV-2 Antige...

Project: EXSCALATE4CoV

Updated at: 29-04-2024

Show more information

Project acronym EXSCALATE4CoV

Periodic Reporting for period 2 - EXSCALATE4CoV (EXaSCale smArt pLatform Against paThogEns for Corona Virus)

Project: EXSCALATE4CoV

Updated at: 28-07-2022

Show more information

Project acronym EXSCALATE4CoV

Resources